CARL ZEISS MEDITEC AG - BR (AFX.DE) Stock Overview
FRA:AFX - DE0005313704 - Common Stock
AFX.DE Key Statistics, Chart & Performance
The current stock price of AFX.DE is 41.36 EUR. In the past month the price decreased by -3.9%. In the past year, price decreased by -29%.
AFX.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABL.DE | ABBOTT LABORATORIES | 27.17 | 198.13B | ||
| 1ISRG.MI | INTUITIVE SURGICAL INC | 58.13 | 143.59B | ||
| IUI1.DE | INTUITIVE SURGICAL INC | 57.44 | 141.67B | ||
| BSX.DE | BOSTON SCIENTIFIC CORP | 37.77 | 135.43B | ||
| 2M6.DE | MEDTRONIC PLC | 16.79 | 101.90B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 19.85 | 53.29B | ||
| BOX.DE | BECTON DICKINSON AND CO | 13.35 | 46.68B | ||
| EWL.DE | EDWARDS LIFESCIENCES CORP | 31.72 | 40.97B | ||
| 1DXCM.MI | DEXCOM INC | 44.81 | 25.13B | ||
| DC4.DE | DEXCOM INC | 44.03 | 25.04B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 16.53 | 22.93B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 16.53 | 22.92B |
Related stock screener links
About AFX.DE
Company Profile
Carl Zeiss Meditec AG engages in the development, manufacture, and marketing of medical devices. The company is headquartered in Jena, Thueringen and currently employs 5,730 full-time employees. The company went IPO on 2000-03-20. The firm offers complete solutions to diagnose and treat ophthalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The firm operates in two segments: ophthalmic devices and microsurgery. The Ophthalmic Devices segment comprises activities in ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiation. Its products include zeiss corneal photographers, slit lamps and accessories, data management software, zeiss intraocular lenses, optical biometers, optical coherence tomography systems, ophthalmic microscopes, refractive lasers are among others. The firm offers related support services.
Company Info
CARL ZEISS MEDITEC AG - BR
Goeschwitzer Strasse 51-52
Jena THUERINGEN DE
Employees: 5730
Phone: 493641220331
CARL ZEISS MEDITEC AG - BR / AFX.DE FAQ
What is the stock price of CARL ZEISS MEDITEC AG - BR today?
The current stock price of AFX.DE is 41.36 EUR. The price decreased by -1.01% in the last trading session.
What is the ticker symbol for CARL ZEISS MEDITEC AG - BR stock?
The exchange symbol of CARL ZEISS MEDITEC AG - BR is AFX and it is listed on the Deutsche Boerse Ag exchange.
On which exchange is AFX.DE stock listed?
AFX.DE stock is listed on the Deutsche Boerse Ag exchange.
What is the price forecast or stock price prediction for CARL ZEISS MEDITEC AG - BR stock?
22 analysts have analysed AFX.DE and the average price target is 56.34 EUR. This implies a price increase of 36.22% is expected in the next year compared to the current price of 41.36. Check the CARL ZEISS MEDITEC AG - BR stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is CARL ZEISS MEDITEC AG - BR worth?
CARL ZEISS MEDITEC AG - BR (AFX.DE) has a market capitalization of 3.70B EUR. This makes AFX.DE a Mid Cap stock.
How many employees does CARL ZEISS MEDITEC AG - BR have?
CARL ZEISS MEDITEC AG - BR (AFX.DE) currently has 5730 employees.
What are the support and resistance levels for CARL ZEISS MEDITEC AG - BR (AFX.DE) stock?
CARL ZEISS MEDITEC AG - BR (AFX.DE) has a support level at 41.35 and a resistance level at 42.92. Check the full technical report for a detailed analysis of AFX.DE support and resistance levels.
Is CARL ZEISS MEDITEC AG - BR (AFX.DE) expected to grow?
The Revenue of CARL ZEISS MEDITEC AG - BR (AFX.DE) is expected to grow by 6.65% in the next year. Check the estimates tab for more information on the AFX.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy CARL ZEISS MEDITEC AG - BR (AFX.DE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AFX.DE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AFX.DE, evaluating the profitability, health, valuation and growth aspects
- CARL ZEISS MEDITEC AG - BR (AFX.DE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CARL ZEISS MEDITEC AG - BR (AFX.DE) Sales and EPS estimates to see what analysts future expectations are.
- CARL ZEISS MEDITEC AG - BR (AFX.DE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CARL ZEISS MEDITEC AG - BR (AFX.DE) Insider and Institutional Ownership to learn about the owners and their transactions.
- CARL ZEISS MEDITEC AG - BR (AFX.DE) Stock Chart to make your own analysis
- CARL ZEISS MEDITEC AG - BR (AFX.DE) Latest news and press-releases to stay up to date.
Does CARL ZEISS MEDITEC AG - BR (AFX.DE) stock pay dividends?
CARL ZEISS MEDITEC AG - BR (AFX.DE) has a dividend yield of 1.44%. The yearly dividend amount is currently 1.11. Check the full fundamental report for a detailed analysis of AFX.DE dividend history, reliability and sustainability.
When does CARL ZEISS MEDITEC AG - BR (AFX.DE) report earnings?
CARL ZEISS MEDITEC AG - BR (AFX.DE) will report earnings on 2025-12-11, after the market close.
What is the Price/Earnings (PE) ratio of CARL ZEISS MEDITEC AG - BR (AFX.DE)?
The PE ratio for CARL ZEISS MEDITEC AG - BR (AFX.DE) is 24.19. This is based on the reported non-GAAP earnings per share of 1.71 and the current share price of 41.36 EUR. Check the full fundamental report for a full analysis of the valuation metrics for AFX.DE.
AFX.DE Technical Analysis
AFX.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to AFX.DE. Both the profitability and the financial health of AFX.DE get a neutral evaluation. Nothing too spectacular is happening here.
AFX.DE Financial Highlights
Over the last trailing twelve months AFX.DE reported a non-GAAP Earnings per Share(EPS) of 1.71. The EPS decreased by -25% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 7.19% | ||
| ROA | 4.49% | ||
| ROE | 7.51% | ||
| Debt/Equity | 0.27 |
AFX.DE Forecast & Estimates
22 analysts have analysed AFX.DE and the average price target is 56.34 EUR. This implies a price increase of 36.22% is expected in the next year compared to the current price of 41.36.
For the next year, analysts expect an EPS growth of -10.07% and a revenue growth 6.65% for AFX.DE